Brief: Jw (Cayman) Therapeutics Says Strategic Partnership With 2Seventy Bio, Inc
02/01/2024 12:05
Jan 2 (Reuters) - JW (Cayman) Therapeutics Co Ltd
2126.HK :
* STRATEGIC PARTNERSHIP WITH 2SEVENTY BIO, INC
* ENTERED INTO AN EXCLUSIVE COLLABORATION AGREEMENT WITH
2SEVENTY
BIO ON JAN 1
* AGREEMENT FOR CO-DEVELOPMENT OF CHIMERIC ANTIGEN RECEPTOR
T CELL
THERAPY PRODUCT FOR AUTOIMMUNE DISEASES IN GREATER CHINA
Further company coverage: 2126.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 2Seventy Bio
See all news2Seventy Bio Inc expected to post a loss of 17 cents a share - Earnings Preview
2Seventy Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: 2Seventy Bio Q4 Basic EPS USD -0.37
2Seventy Bio Inc expected to post a loss of 26 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney